// App-Quantinova.ai

BSH2020‐EP‐028 : Bosutinib real‐world data research study: a single centre, retrospective, non‐interventional, cohort study analysis of pre‐treated chronic myeloid leukaemia patients

Researchers

Presenter

  • M. Drummond

Principal Investigators

  • R. Mitchell

  • K. Amer

  • M. Steigmann

  • S. Purcell

  • S. Mclain-Smith

  • O. Diribe

  • E. Pearce

Medical Centers

  • Haematology Consultant, Beatson West of Scotland Cancer Centre, Glasgow

  • Oncology, Pfizer Ltd., Tadworth

  • Real World Evidence Consulting, OPEN VIE, Marlow, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Angiology

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Peripheral artery disease

  • Chronic Myelogenous Leukemia

  • Thrombocytopenia

  • Hypertension

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Bosutinib

  • L-Tyrosine

  • lipase

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved